Cargando…
Antibody Response against Severe Acute Respiratory Syndrome Coronavirus 2 Messenger Ribonucleic Acid Vaccines in Infected Individuals: A Systematic Review
Individuals with a history of coronavirus disease 2019 (COVID-19) exhibit memory immunity acquired during natural infection. However, a decline in immunity after infection renders these individuals vulnerable to re-infection, in addition to a higher risk of infection with new variants. This systemat...
Autores principales: | Roslan, Madihah, Mohd Nisfu, Farah Ratulfazira, Arzmi, Mohd Hafiz, Abdul Wahab, Ridhwan, Zainuddin, Norafiza |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Penerbit Universiti Sains Malaysia
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10467589/ https://www.ncbi.nlm.nih.gov/pubmed/37655145 http://dx.doi.org/10.21315/mjms2023.30.4.2 |
Ejemplares similares
-
Messenger ribonucleic acid vaccines for severe acute respiratory syndrome coronavirus-2 – a review
por: Akamine, Christine M., et al.
Publicado: (2022) -
Myopericarditis After the Pfizer Messenger Ribonucleic Acid Coronavirus Disease Vaccine in Adolescents
por: Schauer, Jenna, et al.
Publicado: (2021) -
Fulminant Myocarditis 24 Days after Coronavirus Disease Messenger Ribonucleic Acid Vaccination
por: Kawano, Hiroaki, et al.
Publicado: (2022) -
Effectiveness of Messenger Ribonucleic Acid Vaccine in Lung Transplant Recipients
por: Vender, R.J., et al.
Publicado: (2022) -
Long-term evaluation of sperm parameters after coronavirus disease 2019 messenger ribonucleic acid vaccination
por: Diaz, Parris, et al.
Publicado: (2022)